Genetic variants that predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis: current challenges and future directions.

Plenge, Robert M

Genetic variants that predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis: current challenges and future directions. [electronic resource] - Current opinion in rheumatology Mar 2008 - 145-52 p. digital

Publication Type: Journal Article; Review

1040-8711

10.1097/BOR.0b013e3282f5135b doi


Antibodies, Monoclonal--therapeutic use
Arthritis, Rheumatoid--drug therapy
Biomarkers, Pharmacological
Gene Frequency
Humans
Immunologic Factors--pharmacology
Immunosuppressive Agents--pharmacology
Pharmacogenetics
Receptors, Tumor Necrosis Factor--therapeutic use
Tumor Necrosis Factor-alpha--antagonists & inhibitors